Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM-POWR Study.
European journal of haematology
View this publicationEuropean journal of haematology
View this publicationHamostaseologie
View this publicationHaematologica
View this publicationTH open : companion journal to thrombosis and haemostasis
View this publicationThrombosis and haemostasis
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationPloS one
View this publicationArteriosclerosis, thrombosis, and vascular biology
View this publicationHaematologica
View this publicationInternational journal of molecular sciences
View this publication